Pro-inflammatory and autophagy signaling pathways

Pro-inflammatory and autophagy signaling pathways represent an interconnected network of biological cascades that maintain cellular homeostasis and respond to external stressors such as pathogens or nutrient scarcity. Pro-inflammatory signaling, often mediated by the Nuclear Factor-kappa B (NF-κB) and Mitogen-Activated Protein Kinase (MAPK) pathways, triggers the production of cytokines like TNF-α and IL-1β to initiate an immune response (Saitoh & Akira, 2016, Nature Reviews Immunology). Autophagy is a lysosomal degradation process that recycles damaged organelles and proteins, serving as a survival mechanism and a negative regulator of inflammation by clearing pro-inflammatory stimuli like damaged mitochondria or active inflammasomes (Harris et al., 2011, Journal of Clinical Investigation). The mechanistic target of rapamycin (mTOR) acts as a critical node in this crosstalk, functioning as a potent inhibitor of autophagy while promoting anabolic and inflammatory processes (Saxton & Sabatini, 2017, Cell). Dysregulation of the balance between these pathways is central to the pathogenesis of chronic inflammatory diseases, neurodegeneration, and various cancers. For instance, defective autophagy can lead to the accumulation of protein aggregates and persistent NLRP3 inflammasome activation, exacerbating tissue damage (Levine & Kroemer, 2019, Cell). Pharmacological strategies target specific components within these pathways; drugs like Rapamycin induce autophagy by inhibiting mTOR, while biologics like Infliximab neutralize specific inflammatory cytokines to dampen systemic inflammation. Because these pathways are fundamental to cell survival and immune defense, therapeutic intervention requires precise modulation to avoid significant safety concerns, such as severe immunosuppression or the inhibition of essential cellular recycling processes.

Other names

Inflammatory signaling cascadesAutophagic flux regulationNF-kB and mTOR crosstalkCytokine signaling pathways

Modulation of intracellular cascades via inhibition of the mechanistic target of rapamycin (mTOR), sequestration of pro-inflammatory cytokines, or activation of AMP-activated protein kinase (AMPK) to restore cellular homeostasis.